Read about the innovative measures taken by Firestone Liberia, Inc., to successfully limit the spread of Ebola in an area where they had already established an effective health care infrastructure.
Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
Treatment with benralizumab (Fasenra) achieved remission at 36 and 48 weeks at rates similar to those of mepolizumab (Nucala) in a head-to-head phase 3 trial of the two drugs.